Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a non-inferiority, open label, randomized trial of women on buprenorphine Medication Assisted Therapy for opioid use disorder in pregnancy.Patients will be randomized to either the long acting monthly subcutaneous SublocadeTM or to short acting sublingual Suboxone®.
Epistemonikos ID: 40844ec01be8a30da171e610abb836e4f599db45
First added on: May 06, 2024